重组人促红细胞生成素（r-Hu EPO）与L-肉碱联合应用于终末期肾病贫血患者的疗效 - Suppr | 超能文献

Response to recombinant human erythropoietin (r-Hu EPO) and L-carnitine combination in patients with anemia of end-stage renal disease.

作者信息

Boran M, Dalva I, Gönenç F, Cetin S

出版信息

Nephron. 1996;73(2):314-5. doi: 10.1159/000189060.

DOI:10.1159/000189060

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Response to recombinant human erythropoietin (r-Hu EPO) and L-carnitine combination in patients with anemia of end-stage renal disease.重组人促红细胞生成素（r-Hu EPO）与L-肉碱联合应用于终末期肾病贫血患者的疗效

Nephron. 1996;73(2):314-5. doi: 10.1159/000189060.

2

L-carnitine and erythropoietin requirements in hemodialysis patients.血液透析患者对左旋肉碱和促红细胞生成素的需求

Am J Kidney Dis. 1996 Jul;28(1):156. doi: 10.1016/s0272-6386(96)90147-x.

3

[Anemia in chronic renal failure. The role of L-carnitine in the treatment of anemia of hemodialyzed patients].[慢性肾衰竭中的贫血。左旋肉碱在血液透析患者贫血治疗中的作用]

Pol Arch Med Wewn. 2003 Jan;109(1):105-11.

4

Use of Carnitor for Epogen resistant anemia.

ANNA J. 1999 Feb;26(1):41-2.

5

The response to recombinant human erythropoietin in patients with the anemia of end-stage renal disease is correlated with serum carnitine levels.终末期肾病贫血患者对重组人促红细胞生成素的反应与血清肉碱水平相关。

Nephron. 1991;57(1):127-8. doi: 10.1159/000186237.

6

[Combined therapy with L-carnitine and erythropoietin of anemia in chronic kidney failure patients undergoing hemodialysis].[左旋肉碱与促红细胞生成素联合治疗血液透析慢性肾衰竭患者贫血]

Pol Arch Med Wewn. 2007 Jan-Feb;117(1-2):14-9.

7

Comparison of two recombinant erythropoietin formulations in patients with anemia due to end-stage renal disease on hemodialysis: a parallel, randomized, double blind study.两种重组促红细胞生成素制剂在接受血液透析的终末期肾病贫血患者中的比较：一项平行、随机、双盲研究。

BMC Nephrol. 2005 May 23;6:5. doi: 10.1186/1471-2369-6-5.

8

[The importance of erythropoietin in the therapy of anemia in patients on chronic hemodialysis].[促红细胞生成素在慢性血液透析患者贫血治疗中的重要性]

Urol Nefrol (Mosk). 1990 Nov-Dec(6):69-70.

9

Management of iron deficiency in renal anemia: guidelines for the optimal therapeutic approach in erythropoietin-treated patients.肾性贫血中铁缺乏的管理：促红细胞生成素治疗患者最佳治疗方法指南

Clin Nephrol. 1997 Jul;48(1):1-8.

10

Erythropoietin.促红细胞生成素

Aust Nurses J. 1990 Sep;20(2):29.

引用本文的文献

1

The management of anemia in pediatric peritoneal dialysis patients. Guidelines by an ad hoc European committee.儿童腹膜透析患者贫血的管理。欧洲特设委员会指南

Pediatr Nephrol. 2003 Aug;18(8):805-9. doi: 10.1007/s00467-003-1126-0. Epub 2003 May 15.